frovatriptan 2.5 MG Oral Tablet
1 INDICATIONS AND USAGE Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with frovatriptan succinate tablets, reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks. Frovatriptan succinate tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of frovatriptan succinate tablets have not been established for cluster headache. Frovatriptan succinate is a serotonin (5-HT 1B / 1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use Use only after a clear diagnosis of migraine has been established. ( 1 ) Not indicated for the prophylactic therapy of migraine. ( 1 ) Not indicated for the treatment of cluster headache. ( 1 )
amneal pharmaceuticals ny llc
ROUND WHITE A5
Related Pills
21 Ethinyl Estradiol 0.03 MG Levonorgestrel 0.15 MG Oral Tablet 7 Inert Ingredients 1 MG Oral Tablet Pack Marlissa 28 Day
glenmark pharmaceuticals inc., usa
APAP 500 MG Oral Tablet
RUGBY LABORATORIES, INC.
APAP 500 MG Oral Tablet
RUGBY LABORATORIES, INC.
Divalproex Sodium 24 HR Divalproex Sodium 500 MG Extended Release Oral Tablet
Par Pharmaceutical, Inc.
Paroxetine Paroxetine 40 MG Oral Tablet
Clinical Solutions Wholesale
Pain and Fever Acetaminophen 500 MG Oral Tablet
RUGBY LABORATORIES, INC.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
FROVATRIPtan SUCCINATE Tablets, 2.5 mg are supplied as white to off-white, round shaped, biconvex, film-coated tablets, debossed with ‘A5’ on one side and plain on other side. They are available as follows: Carton of 9 Tablets: NDC 69238-1539-9 (Packages of 9 unit doses, 1 card of 9 tablets each) Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from moisture.
More pills like ROUND A5